The phase II AMPLIFY-7P trial evaluated camupepimut (ELI-002 7P) in resected KRAS-mutated pancreatic cancer. Watch @EileenMOReilly discuss the trial 👉 https://bit.ly/4soSBfp #ESMO2

ecancer· @ecancer · X·2026-10-24 22:34· 16 hours agoScore70

Body · original

The phase II AMPLIFY-7P trial evaluated camupepimut (ELI-002 7P) in resected KRAS-mutated pancreatic cancer. Watch @EileenMOReilly discuss the trial 👉 https://bit.ly/4soSBfp #ESMO2026.

69 views · 1 like · 0 reposts · 0 replies

Conference abstracts

7Pmatched by Proffered paper 1: Gastrointestinal tumour, upper digestive

Proffered paper 1: Gastrointestinal tumour, upper digestive

https://esmocongress.esmo.org

Source: ecancer · x.com